Proteomics and COVID-19: Recent Trends

Proteomics has been found to be a helpful tool in understanding COVID-19 disease. It has provided important insights into the complex interactions between the SARS-CoV-2 virus and its host. Proteomics, a branch of molecular biology focused on studying proteins and their functions, has played a pivotal role in deciphering the molecular mechanisms underlying infection, pathogenesis, and immune responses associated with COVID-19. Researchers have utilized sophisticated proteomic techniques like mass spectrometry and high-throughput quantification methods to identify and characterize viral proteins, revealing insights into their functions in viral replication and pathogenicity. Concurrently, proteomic analysis of host cells and tissues has unveiled dynamic changes in protein expression patterns during infection, offering a comprehensive view of the host response. The field of proteomics has contributed to the discovery of biomarkers indicating illness severity and prognosis, along with potential treatment targets. By unraveling the complex interactions between viral proteins and host factors, proteomics has played a crucial role in devising innovative approaches for therapeutic interventions and vaccine development. Additionally, proteomic studies have provided insights into the immune response elicited by SARS-CoV-2, revealing crucial information about signaling pathways and cytokine profiles that impact the course of the disease. This knowledge has implications for the design of immunomodulatory therapies and vaccines.